Biodel Inc.: Approximately 3,085,500 shares changed hands, a 1,410.7 percent increase over its 65- day average volume. The shares rose$. 11 or 10.7 percent to $1.14. Celsion Corp.: Approximately 8,131,600 shares changed hands, a 4,116.8 percent increase over its 65- day average volume.
Celsion shares were downgraded Thursday, right in front of an announcement of clinical trial results for its Thermodox liver cancer therapy.
TheStreet.com details the 10 best-performing biopharmaceutical stocks of 2012 and their outlook for 2013.
Hedge funds peeled back the curtain this week to reveal a bit about what biotech stocks they were buying and selling during the second quarter.